UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 11, 2026
Accession Number:
0001178913-26-002444
Submission Type:
POS AM
CIK:
0002022416
Company Name:
Silexion Therapeutics Corp
File Number:
333-290074